EUVIMEDEUVIMED entdecken
Fallbericht

Pulsed‐dye laser as an effective treatment for recalcitrant granulomatous rosacea and a potential regulator of CXCL9 expression

Ji Eun Maeng, Sun Woo Son iD, Soo-Jin Lee, Jin Cheol Kim iD, Seokhwi Kim, Hee Young Kang, Young Joon Park

The Journal of Dermatology · 2024

DOI: 10.1111/1346-8138.17051 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Dermatology, 2024. Verfasst von Ji Eun Maeng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Ajou University School of Medicine, Suwon, Korea. Hauptthemen laut MEDLINE: Chemokine CXCL9, Fibroblasts, Lasers, Dye, Rosacea. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Amorepacific grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Granulomatous rosacea (GR) is a rare and distinct variant of rosacea. We report three cases of recalcitrant GR successfully treated with pulsed‐dye laser (PDL) and provide experimental evidence supporting its potential as a treatment option. PDL treatment demonstrated remarkable efficacy in the three clinical cases, despite their resistance to conventional therapies. Chemokine ligand 9 (CXCL9), a key chemokine involved in inflammation and granuloma formation, was found to be increased in skin sections from all three patients. In vitro experiments using human monocytes and dermal fibroblasts demonstrated that PDL treatment significantly reduced CXCL9 expression in fibroblasts. These findings suggest that PDL may modulate CXCL9 secretion in fibroblasts, potentially limiting the recruitment of immune cells to the lesion. Although further research is needed to fully understand the precise mechanisms underlying the role of CXCL9 in GR, PDL may be a promising therapeutic approach for refractory GR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemokine CXCL9FibroblastsLasers, DyeRosaceaAdultFemaleHumansMaleMiddle AgedLow-Level Light TherapyMonocytesSkinTreatment Outcome

Stichwörter der Autor:innen

CXCL9granulomagranulomatous rosaceapulsed‐dye laserrosacea

Substanzen

Chemokine CXCL9CXCL9 protein, human

Autor:innen und Institutionen

  • Department of Dermatology, Ajou University School of Medicine, Suwon, Korea.
  • Department of Dermatology, Chungbuk National University School of Medicine, Cheongju, Korea.
  • Department of Pathology, Ajou University School of Medicine, Suwon, Korea.

ORCID-Profile: Sun Woo Son, Jin Cheol Kim

Förderung

  • Amorepacific grant

Zitieren

APA

Maeng, J. E., Son, S. W., Lee, S. J., Kim, J. C., Kim, S., Kang, H. Y., & Park, Y. J. (2024). Pulsed‐dye laser as an effective treatment for recalcitrant granulomatous rosacea and a potential regulator of CXCL9 expression. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17051

Vancouver

Maeng JE, Son SW, Lee SJ, Kim JC, Kim S, Kang HY, et al. Pulsed‐dye laser as an effective treatment for recalcitrant granulomatous rosacea and a potential regulator of CXCL9 expression. The Journal of Dermatology. 2024. doi:10.1111/1346-8138.17051

BibTeX
@article{Maeng2024,
  author = {Maeng, Ji Eun and Son, Sun Woo and Lee, Soo-Jin and Kim, Jin Cheol and Kim, Seokhwi and Kang, Hee Young and Park, Young Joon},
  title = {Pulsed‐dye laser as an effective treatment for recalcitrant granulomatous rosacea and a potential regulator of CXCL9 expression},
  journal = {The Journal of Dermatology},
  year = {2024},
  doi = {10.1111/1346-8138.17051}
}
Kostenlos starten →